CAR-T Therapy Steering Committee


To build and advance the supply chain of this nascent medical science to deliver affordable healthcare; to address the “Commercialization and Scaling Up of CAR-T Cell Therapy Supply Chain” through its incorporation of agility, accountability, quality and integrity in the business end-to-end.

CO-CHAIRPERSONS: Shankar Suryanarayanan, Global Operations Leader, Pharmaceuticals and Medical Devices, Baxter International and Laura Alquist, Vice President, Supply Chain, Kite Pharma

  • Dr. Alison Moore, CTO, Allogene Therapeutics
  • Jayant Aphale, Executive Vice President of Technical Operations, Gritstone Oncology
  • Kimberly Lounds Foster, Corporate Vice President and Head of Global Commercial Supply, Celgene
  • Neil Ackerman, Senior Director, Enterprise Supply Chain Global Planning and Innovation, Johnson and Johnson
  • Bernard Huyghe, Senior Director, External Supply, Allogene Therapeutics, Inc.
  • Franck Toussaint, Managing Director, Biolog Europe
  • Matthew Yedwabnick ,  Sr. Director Supply Chain , Atara Biotherapeutics
  • Phillip Shaw, Vice President, Global Supply Chain, Gilead Sciences
  • Karen Walker, Vice President, Global Quality, Seattle Genomics
  • Kirstin Powell, Global Head External Quality Operations, CGTDM, Novartis
  • Carlo Guy, Vice President, Supply Chain, CAR-T Cell,  Novartis
  • Kenneth Locke, Global Head, Strategic Sourcing – Cell Therapies, Celgene
  • Reggie Foster, Director Logistics and Packaging Engineering, Kite Pharma
  • Howard Bland, Sr. Director, Sourcing & Procurement, Kite Pharma